{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T05:32:08Z","timestamp":1789104728806,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T00:00:00Z","timestamp":1756080000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016290","name":"Insamlingsstiftelsen Cancer- och Allergifonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007232","name":"Cancer Research Foundations of Radiumhemmet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.tranon.2025.102512","type":"journal-article","created":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T03:23:20Z","timestamp":1756351400000},"page":"102512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo"],"prefix":"10.1016","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6104-6446","authenticated-orcid":false,"given":"Johan","family":"Nilvebrant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos Fern\u00e1ndez","family":"Moro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Papalanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masih Ostad","family":"Novin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haozhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1518-2241","authenticated-orcid":false,"given":"Ruonan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Oroujeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9854-2048","authenticated-orcid":false,"given":"Arun","family":"Selvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9la","family":"Boz\u00f3ky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5391-600X","authenticated-orcid":false,"given":"Torbj\u00f6rn","family":"Gr\u00e4slund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7373-8730","authenticated-orcid":false,"given":"Timea","family":"Szekerczes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7694-6420","authenticated-orcid":false,"given":"Tatiana","family":"Sandalova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Salter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0432-710X","authenticated-orcid":false,"given":"Adnane","family":"Achour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Tolmachev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Bj\u00f6rnstedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4214-6991","authenticated-orcid":false,"given":"Per-\u00c5ke","family":"Nygren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2025.102512_bib0001","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-024-07487-w","article-title":"Accurate structure prediction of biomolecular interactions with AlphaFold 3","author":"Abramson","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2025.102512_bib0002","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.nucmedbio.2010.02.009","article-title":"Kit formulation for 99mTc-labeling of recombinant anti-HER2 affibody molecules with a C-terminally engineered cysteine","volume":"37","author":"Ahlgren","year":"2010","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.tranon.2025.102512_bib0003","doi-asserted-by":"crossref","first-page":"700","DOI":"10.2967\/jnumed.123.266847","article-title":"Human epidermal growth factor receptor 2 (HER2) PET imaging of HER2-low breast cancer with [(68)Ga]Ga-ABY-025: results from a pilot study","volume":"65","author":"Altena","year":"2024","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.tranon.2025.102512_bib0004","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/521274a","article-title":"Reproducibility crisis: blame it on the antibodies","volume":"521","author":"Baker","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2025.102512_bib0005","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1007\/s13277-013-1033-3","article-title":"Biomarkers for pancreatic cancer: promising new markers and options beyond CA 19-9","volume":"34","author":"Ballehaninna","year":"2013","journal-title":"Tumour. Biol."},{"key":"10.1016\/j.tranon.2025.102512_bib0006","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nbt1127","article-title":"Engineering novel binding proteins from nonimmunoglobulin domains","volume":"23","author":"Binz","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tranon.2025.102512_bib0007","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-5793(00)01612-4","article-title":"Structural models for carcinoembryonic antigen and its complex with the single-chain fv antibody molecule MFE23","volume":"475","author":"Boehm","year":"2000","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tranon.2025.102512_bib0008","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jconrel.2022.09.004","article-title":"Affibody-mediated controlled release of fibroblast growth factor 2","volume":"350","author":"Bostock","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.tranon.2025.102512_bib0009","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/518027a","article-title":"Reproducibility: standardize antibodies used in research","volume":"518","author":"Bradbury","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.tranon.2025.102512_bib0010","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.7150\/thno.86770","article-title":"Phase I clinical evaluation of (99m)Tc-labeled Affibody molecule for imaging HER2 expression in breast cancer","volume":"13","author":"Bragina","year":"2023","journal-title":"Theranostics."},{"key":"10.1016\/j.tranon.2025.102512_bib0011","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0140-6736(94)92695-6","article-title":"Phage libraries for generation of clinically useful antibodies","volume":"343","author":"Chester","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.tranon.2025.102512_bib0012","doi-asserted-by":"crossref","first-page":"6589","DOI":"10.1158\/1078-0432.CCR-19-4051","article-title":"Preclinical activity of SAR408701: a novel Anti-CEACAM5-maytansinoid antibody-drug conjugate for the treatment of CEACAM5-positive epithelial tumors","volume":"26","author":"Decary","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.tranon.2025.102512_bib0013","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12051088","article-title":"Affibody PET imaging of HER2-expressing cancers as a key to guide HER2-targeted therapy","volume":"12","author":"Eissler","year":"2024","journal-title":"Biomedicines."},{"key":"10.1016\/j.tranon.2025.102512_bib0014","first-page":"237","article-title":"Breast-tumor xenograft targeting and therapy studies using radiolabeled chimeric anti-cea monoclonal-antibody t84.66","volume":"2","author":"Esteban","year":"1995","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tranon.2025.102512_bib0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166067","article-title":"Immunohistochemical typing of adenocarcinomas of the pancreatobiliary system improves diagnosis and prognostic stratification","volume":"11","author":"Fernandez Moro","year":"2016","journal-title":"PLoS. One"},{"key":"10.1016\/j.tranon.2025.102512_bib0016","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s41181-020-00094-w","article-title":"Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond","volume":"5","author":"Garousi","year":"2020","journal-title":"EJNMMI. Radiopharm. Chem."},{"key":"10.1016\/j.tranon.2025.102512_bib0017","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/bjd\/ljad186","article-title":"Izokibep for the treatment of moderate-to-severe plaque psoriasis: a phase II, randomized, placebo-controlled, double-blind, dose-finding multicentre study including long-term treatment","volume":"189","author":"Gerdes","year":"2023","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.tranon.2025.102512_bib0018","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.nbt.2023.09.002","article-title":"Affibody-based hBCMA x CD16 dual engagers for NK cell-mediated killing of multiple myeloma cells","volume":"77","author":"Giang","year":"2023","journal-title":"N. Biotechnol."},{"key":"10.1016\/j.tranon.2025.102512_bib0019","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/978-1-0716-3381-6_19","article-title":"Selection of affibody affinity proteins from Phagemid libraries","volume":"2702","author":"Giang","year":"2023","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tranon.2025.102512_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/2191-219X-1-24","article-title":"Targeting CEA in pancreas cancer xenografts with a mutated scFv-fc antibody fragment","volume":"1","author":"Girgis","year":"2011","journal-title":"EJNMMI. Res."},{"key":"10.1016\/j.tranon.2025.102512_bib0021","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/scbi.1998.0119","article-title":"The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues","volume":"9","author":"Hammarstrom","year":"1999","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.tranon.2025.102512_bib0022","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/0969-8051(94)90175-9","article-title":"Can a cysteine challenge assay predict the in vivo behavior of 99mTc-labeled antibodies?","volume":"21","author":"Hnatowich","year":"1994","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.tranon.2025.102512_bib0023","first-page":"3055","article-title":"Minibody: a novel engineered anti-carcinoembryonic antigen antibody fragment (single-chain Fv-CH3) which exhibits rapid, high-level targeting of xenografts","volume":"56","author":"Hu","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2025.102512_bib0024","doi-asserted-by":"crossref","first-page":"15152","DOI":"10.1021\/jacs.5b08424","article-title":"Carbohydrate-aromatic interactions in proteins","volume":"137","author":"Hudson","year":"2015","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.tranon.2025.102512_bib0025","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1039\/D2CB00094F","article-title":"Protein scaffolds: antibody alternatives for cancer diagnosis and therapy","volume":"3","author":"Luo","year":"2022","journal-title":"RSC. Chem. Biol."},{"key":"10.1016\/j.tranon.2025.102512_bib0026","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15112923","article-title":"PDAC, the Influencer Cancer: cross-talk with tumor microenvironment and connected potential therapy strategies","volume":"15","author":"Mercanti","year":"2023","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.tranon.2025.102512_bib0027","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41592-022-01488-1","article-title":"ColabFold: making protein folding accessible to all","volume":"19","author":"Mirdita","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.tranon.2025.102512_bib0028","first-page":"2329","article-title":"Specificity and affinity of monoclonal antibodies against carcinoembryonic antigen","volume":"52","author":"Nap","year":"1992","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2025.102512_bib0029","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1177\/172460089200700305","article-title":"Immunohistology of carcinoembryonic antigen (CEA). Specificity of reagents, choice of control tissues and practical application in surgical pathology","volume":"7","author":"Nap","year":"1992","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.tranon.2025.102512_bib0030","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nbt0897-772","article-title":"Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain","volume":"15","author":"Nord","year":"1997","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tranon.2025.102512_bib0031","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1016\/S0021-9258(18)96497-5","article-title":"The release of enzymes by osmotic shock from Escherichia coli in exponential phase","volume":"241","author":"Nossal","year":"1966","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tranon.2025.102512_bib0032","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1111\/j.1742-4658.2008.06438.x","article-title":"Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold","volume":"275","author":"Nygren","year":"2008","journal-title":"FEBS. J."},{"key":"10.1016\/j.tranon.2025.102512_bib0033","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22052770","article-title":"Preclinical evaluation of (99m)Tc-ZHER2:41071, a second-generation affibody-based HER2-visualizing imaging probe with a low renal uptake","volume":"22","author":"Oroujeni","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2025.102512_bib0034","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.5858\/2007-131-1561-POIMHD","article-title":"Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma","volume":"131","author":"Park","year":"2007","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.tranon.2025.102512_bib0035","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1001\/jama.2021.20068","article-title":"A review of pancreatic cancer-reply","volume":"326","author":"Park","year":"2021","journal-title":"JAMa"},{"key":"10.1016\/j.tranon.2025.102512_bib0036","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2217964","article-title":"Generation and in vivo characterization of a novel high-affinity human antibody targeting carcinoembryonic antigen","volume":"15","author":"Pluss","year":"2023","journal-title":"MAbs."},{"key":"10.1016\/j.tranon.2025.102512_bib0037","doi-asserted-by":"crossref","first-page":"11078","DOI":"10.1021\/acsami.1c21655","article-title":"Affimer tagged cubosomes: targeting of carcinoembryonic antigen expressing colorectal cancer cells using In Vitro and In vivo models","volume":"14","author":"Pramanik","year":"2022","journal-title":"ACS. Appl. Mater. Interfaces."},{"key":"10.1016\/j.tranon.2025.102512_bib0038","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ijbiomac.2006.03.022","article-title":"Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen","volume":"39","author":"Sainz-Pastor","year":"2006","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.tranon.2025.102512_bib0039","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/s41598-020-80354-6","article-title":"Selection and characterisation of Affimers specific for CEA recognition","volume":"11","author":"Shamsuddin","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2025.102512_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1464088","article-title":"Novel anti-CEA affibody for rapid tumor-targeting and molecular imaging diagnosis in mice bearing gastrointestinal cancer cell lines","volume":"15","author":"Shao","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.tranon.2025.102512_bib0041","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12951-019-0468-0","article-title":"Nanobody-horseradish peroxidase fusion protein as an ultrasensitive probe to detect antibodies against Newcastle disease virus in the immunoassay","volume":"17","author":"Sheng","year":"2019","journal-title":"J. Nanobiotechnology."},{"key":"10.1016\/j.tranon.2025.102512_bib0042","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7150\/thno.13502","article-title":"Measuring HER2-receptor expression In metastatic breast cancer using [68Ga]ABY-025 affibody PET\/CT","volume":"6","author":"Sorensen","year":"2016","journal-title":"Theranostics."},{"key":"10.1016\/j.tranon.2025.102512_bib0043","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.tibtech.2017.04.007","article-title":"Affibody molecules in biotechnological and medical applications","volume":"35","author":"Stahl","year":"2017","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.tranon.2025.102512_bib0044","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/15384047.2021.1941584","article-title":"Biomarkers for early detection of pancreatic cancer - miRNAs as a potential diagnostic and therapeutic tool?","volume":"22","author":"Tarasiuk","year":"2021","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tranon.2025.102512_bib0045","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2144\/000113489","article-title":"The case for trypsin release of affinity-selected phages","volume":"49","author":"Thomas","year":"2010","journal-title":"Biotechniques"},{"key":"10.1016\/j.tranon.2025.102512_bib0046","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030651","article-title":"Affibody molecules as targeting vectors for PET imaging","volume":"12","author":"Tolmachev","year":"2020","journal-title":"Cancers. (Basel)"},{"key":"10.1016\/j.tranon.2025.102512_bib0047","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2967\/jnumed.109.069823","article-title":"In vitro analysis and in vivo tumor targeting of a humanized, grafted nanobody in mice using pinhole SPECT\/micro-CT","volume":"51","author":"Vaneycken","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.tranon.2025.102512_bib0048","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3892\/mmr.2017.6677","article-title":"A nanobody targeting carcinoembryonic antigen as a promising molecular probe for non-small cell lung cancer","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.tranon.2025.102512_bib0049","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jso.2930470303","article-title":"Pancreatoduodenal carcinoma: a clinicopathologic study of 304 patients and immunohistochemical observation for CEA and CA19-9","volume":"47","author":"Yamaguchi","year":"1991","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.tranon.2025.102512_bib0050","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0022-1759(01)00388-X","article-title":"Mammalian expression and hollow fiber bioreactor production of recombinant anti-CEA diabody and minibody for clinical applications","volume":"253","author":"Yazaki","year":"2001","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.tranon.2025.102512_bib0051","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/027245799315899","article-title":"Expression and characterization of anti-NCA-95 scFv (CEA 79 scFv) in a prokaryotic expression vector modified to contain a sfi I and not I site","volume":"18","author":"Yi","year":"1999","journal-title":"Hybridoma"},{"key":"10.1016\/j.tranon.2025.102512_bib0052","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12885-023-10524-y","article-title":"The optimal minimum lymph node count for carcinoembryonic antigen elevated colon cancer: a population-based study in the SEER set and external set","volume":"23","author":"Zhang","year":"2023","journal-title":"BMC. Cancer"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325002438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523325002438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T14:51:02Z","timestamp":1772895062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523325002438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":52,"alternative-id":["S1936523325002438"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102512","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An anti-CEA affibody showing high-definition staining in human pancreatic cancer tissue sections and selective tumor targeting in vivo","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2025.102512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102512"}}